Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (SPECTRA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03738150
Recruitment Status : Completed
First Posted : November 13, 2018
Last Update Posted : March 29, 2022
Information provided by (Responsible Party):
Acceleron Pharma Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 21, 2021
Actual Study Completion Date : March 22, 2022